rdf:type |
|
lifeskim:mentions |
umls-concept:C0005791,
umls-concept:C0018183,
umls-concept:C0018956,
umls-concept:C0439849,
umls-concept:C0439859,
umls-concept:C0445223,
umls-concept:C0574032,
umls-concept:C1514468,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C1710066,
umls-concept:C2745955
|
pubmed:issue |
7
|
pubmed:dateCreated |
2007-6-21
|
pubmed:abstractText |
Adverse events (AEs) after hematopoietic progenitor cell (HPC) infusion are rare but might be life-threatening. These reactions have traditionally been associated with the amount of infused cryoprotectant, but persistence of such events after dimethyl sulfoxide (DMSO) depletion has questioned this assumption.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0041-1132
|
pubmed:author |
pubmed-author:BaconA WAW,
pubmed-author:CaillotDenisD,
pubmed-author:CalmelsBorisB,
pubmed-author:ChabannonChristianC,
pubmed-author:CharbonnierAudeA,
pubmed-author:DeconinckEricE,
pubmed-author:EsterniBenjaminB,
pubmed-author:LadaiquePatrickP,
pubmed-author:LapierreValérieV,
pubmed-author:LemariéClaudeC,
pubmed-author:MaluganiCarolineC,
pubmed-author:ViretFrédéricF,
pubmed-author:de ColellaJean-Marc SchianoJM
|
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1268-75
|
pubmed:meshHeading |
pubmed-meshheading:17581163-Adolescent,
pubmed-meshheading:17581163-Adult,
pubmed-meshheading:17581163-Aged,
pubmed-meshheading:17581163-Blood Cell Count,
pubmed-meshheading:17581163-Blood Component Removal,
pubmed-meshheading:17581163-Data Collection,
pubmed-meshheading:17581163-Dimethyl Sulfoxide,
pubmed-meshheading:17581163-Female,
pubmed-meshheading:17581163-Granulocytes,
pubmed-meshheading:17581163-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:17581163-Humans,
pubmed-meshheading:17581163-Incidence,
pubmed-meshheading:17581163-Male,
pubmed-meshheading:17581163-Middle Aged,
pubmed-meshheading:17581163-Neoplasms,
pubmed-meshheading:17581163-Prospective Studies,
pubmed-meshheading:17581163-Quality Control,
pubmed-meshheading:17581163-Severity of Illness Index,
pubmed-meshheading:17581163-Transplantation, Autologous
|
pubmed:year |
2007
|
pubmed:articleTitle |
Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
|
pubmed:affiliation |
Centre de Thérapie Cellulaire et Génique, Institut Paoli-Calmettes, Centre Régional de Lutte Contre le Cancer Provence-Alpes-Côte d'Azur, 13273 Marseille Cedex 9, France. calmelsb@marseille.fnclcc.fr
|
pubmed:publicationType |
Journal Article
|